Obesity and STDs Could Make $IVOB Even Bigger!
September 8th, 2009 at 6:31 am Posted by The Dean
WARNING: $IVOB May Cause Weight Gain!
As the CollegeStock Community is growing to expect, The Dean’s working overtime to bring you relevant and compelling information about his Ivy League Stock Picks.
The Dean’s running with $IVOB because he feels their chances for success in the infertility drug market are beyond his wildest dreams. With more than 150 million infertile couples out there in the world, The Dean believes there’s a definite NEED for a more efficient, cost-effective infertility treatment like $IVOB‘s INVO procedure.
The Dean has done his homework on contributing factors for infertility and knows that they’re abundant. This could mean that $IVOB‘s chances to become a billion dollar company increase like Americans’ waistlines and sex drives everyday.
That’s right! The Dean thinks that two factors contributing the most to the massive and increasing infertile population are obesity and sexual transmitted diseases (STDs) because both are known to cause serious damage to the human body.
The American Social Health Association reports that 65 million people have some type of STD and that number increases by as much as 19 million new cases every year—that’s a 29% annual increase. If America is a “safer sex” nation, then just think about how many more people could use $IVOB‘s treatment around the world.
Particularly in women, because let’s face it, their body is where conception happens, STDs like chlamydia and gonorrhea can cause infertility and Pelvic Inflammatory Disease (PID) which is linked directly to scarring of the reproductive organs. This is obviously bad news for women but, with $IVOB‘s treatment, they can know that they have another OPTION.
Men can also be affected and in the US it’s estimated that 50% of the people infected with these types of infections do not seek medical attention and do not know about the problem till it’s too late. The Dean believes this makes for more sterile males which can lead to infertile couples—after all, it takes two to tango.
As The Dean taught his students his his lessons about $VNTA, obesity is a LARGE problem, especially in American society. Men who are 20 pounds or more overweight are 10% more likely to be infertile. And that’s nothing when compared to obese women who are 43% less likely to achieve pregnancy.
Obese populations are increasing and diabetes seems to follow directly behind. In fact, diabetes is expected to increase 50% in the next 10 years.
The Dean thinks these factors are significant and create an even larger market for $IVOB‘s INVOcell treatment which could mean maternity pants for everyone!
Sign up to become The Dean’s newest Honors Student and receive access to The Dean’s Ivy League Stock Picks before the rest of the CollegeStock Community.
The Dean is so accessible that you can even connect with him by texting ‘thedean‘ to 69302 on your wireless phone. Try it TODAY!
Watch The Dean on Wide World of Stocks Television
some volume today Dean. I agree than IVOB could be big time
You’re right Marissa. I’m waiting to see what happens in the long run.